Limited intra-individual variability in hypoxanthine-guanine phosphoribosyl transferase, thiopurine S-methyl transferase, and xanthine oxidase activity in inflammatory bowel disease patients during 6-thioguanine therapy

Nucleosides, Nucleotides and Nucleic Acids

Volumn 29, Issue 4-6, 2010, Pages 284-290

  Van Asseldonk, D P ^a   De Boer, N K H ^a   Smid, K ^a   Mulder, C J ^a   Van Bodegraven, A A ^a   Peters, G J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

6 thioguanine; Hypoxanthine guanine phosphoribosyl transferase; inflammatory bowel diseases; thiopurine S methyl transferase; xanthine oxidase

Indexed keywords

AZATHIOPRINE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; MERCAPTOPURINE; THIOPURINE METHYLTRANSFERASE; TIOGUANINE; XANTHINE OXIDASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG METABOLISM; ENTERITIS; ENZYME ACTIVITY; ENZYME METABOLISM; ERYTHROCYTE; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMA; REMISSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE DRUG DOSE; TREATMENT DURATION;

ADULT; ANTIMETABOLITES, ANTINEOPLASTIC; FEMALE; GENOTYPE; HUMANS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; INFLAMMATORY BOWEL DISEASES; MALE; METHYLTRANSFERASES; MIDDLE AGED; THIOGUANINE; XANTHINE OXIDASE;

EID: 77953698608     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257771003730052     Document Type: Article

References (15)

1. Pearson, D.C.; May, G.R.; Fick, G.; Sutherland, L.R. Azathioprine for maintaining remission of Crohn's disease. Cochrane Database Syst. Rev. 2000, CD000067.
2. Timmer, A.; McDonald, J.W.; MacDonald, J.K. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev. 2007, CD000478.
3. Derijks, L.J.J.; Gilissen, L.P.L.; Engels, L.G.J.B.; Bos, L.P.; Bus, P.J.; Lohman, J.J.H.M.; van Deventer, S.J.H.; Hommes, D.W.; Hooymans, P.M. Pharmacokinetics of 6-thioguanine in patients with inflammatory bowel disease. Ther. Drug Monit. 2006, 28, 45-50.
4. Yates, C.R.; Krynetski, E.Y.; Loennechen, T.; Fessing, M.Y.; Tai, H.L.; Pui, C.H.; Relling, M.V.; Evans, W.E. Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance. Ann. Intern. Med. 1997, 126, 608-614.
5. Peters, G.J. and Veerkamp, J.H. Concentration, synthesis and utilization of phosphoribosylpyrophosphate in lymphocytes of five mammalian species. Int. J. Biochem. 1979, 10, 885-888.
6. Tax, W.J.; Veerkamp, J.H.; Trijbels, J.M. Activity of purine phosphoribosyltransferases and of two enzymes of pyrimidine biosynthesis in erythrocytes of ten mammalian species. Comp. Biochem. Physiol. B 1976, 54, 209-212.
7. Keizer-Garritsen, J.J.; Brouwer, C.; Lambooy, L.H.; Ter, R.P.; Bokkerink, J.P.; Trijbels, F.J.; De Abreu, R.A. Measurement of thiopurine S-methyltransferase activity in human blood samples based on high-performance liquid chromatography: reference values in erythrocytes from children. Ann. Clin. Biochem. 2003, 40, 86-93.
8. Dilger, K.; Schaeffeler, E.; Lukas, M.; Strauch, U.; Herfarth, H.; Muller, R.; Schwab, M. Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine. Ther. Drug Monit. 2007, 29, 1-5.
9. Daperno, M.; Sostegni, R.; Canaparo, R.; Serpe, L.; Lavagna, A.; Crocella, L.; Castagno, F.; Vernetto, A.; Rigazio, C.; Ercole, E.; D'Antico, S.; Pera, A.; Zara, G.; Rocca, R. Prospective study of the effects of concomitant medications on thiopurine metabolism in inflammatory bowel disease. Aliment. Pharmacol. Ther. 2009, doi:10.1111/j.1365-2036.2009.04106.x-
10. Schaeffeler, E.; Fischer, C.; Brockmeier, D.; Wernet, D.; Moerike, K.; Eichelbaum, M.; Zanger, U.M.; Schwab, M. Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants. Pharmacogenetics 2004, 14, 407-417.
11. Lennard, L.; Van Loon, J.A.; Lilleyman, J.S.; Weinshilboum, R.M. Thiopurine pharmacogenetics in leukemia: correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations. Clin. Pharmacol. Ther. 1987, 41, 18-25.
12. Raivio, K.O. and Hovi, T. Purine reutilization in phytohemagglutinin- stimulated human Tlymphocytes. Exp. Cell Res. 1978, 116, 75-83.
13. Peters, G.J. and Veerkamp, J.H. Purine and pyrimidine metabolism in peripheral blood lymphocytes. Int. J. Biochem. 1983, 15, 115-123.
14. Spigelman, A.D.; Farmer, K.C.; Oliver, S.; Nugent, K.P.; Bennett, P.N.; Notarianni, L.J.; Dobrocky, P.; Phillips, R.K. Caffeine phenotyping of cytochrome P4501A2, N-acetyltransferase, and xanthine oxidase in patients with familial adenomatous polyposis. Gut 1995, 36, 251-254.
15. Jetter, A.; Kinzig, M.; Rodamer, M.; Tomalik-Scharte, D.; Sorgel, F.; Fuhr, U. Phenotyping of Nacetyltransferase type 2 and xanthine oxidase with caffeine: when should urine samples be collected? Eur. J. Clin. Pharmacol. 2009, 65, 411-417.